What is this study trying to find out about dentin hypersensitivity?

This study is evaluating how well casein phosphopeptide paste (CPP-ACP) alone or combined with a diode laser treatment reduces dentin hypersensitivity pain. Researchers want to understand if combining these treatments offers better relief. The study is sponsored by Dow University of Health Sciences and aims to improve options for people with sensitive teeth.

Who may be eligible for this dentin hypersensitivity clinical trial?

Adults aged 25 to 65 years with at least one sensitive and vital tooth without decay or defective restoration may be eligible. The study accepts all genders but excludes those who have had recent desensitizing therapy, are pregnant, or smoke. Please review eligibility criteria for more details.

Is there any cost to participate in this dentin hypersensitivity clinical trial?

Study-related care, including the study treatments and all trial visits, is provided at no cost. However, personal travel and other expenses may vary and are not guaranteed to be covered.

Actively Recruiting

Phase Not Applicable

Age: 25Years - 65Years

All Genders

Healthy Volunteers

ID06463938

A Clinical Study to Evaluate the Effectiveness of Casein Phosphopeptide Amorphous Calcium Phosphate Paste Alone or with Lasotronix Diode Laser to Treat Dentin Hypersensitivity

Led by Dow University of Health Sciences · Updated on 2024-07-26

120

Participants Needed

Research Sites

8 weeks

Total Duration

AI-Summary

What this Trial Is About

Dentin hypersensitivity DH causes sharp, short pain from exposed dentin triggered by chemicals, temperature, or touch. It commonly affects older adults and varies widely in prevalence. This research evaluates the effectiveness of Casein phosphopeptide paste CPP-ACP alone or combined with a diode laser called Lasotronix in treating DH, as limited studies have explored this combination. The study involves four groups one receiving CPP-ACP paste application only, one receiving diode laser therapy only, a third receiving both CPP-ACP and laser treatments, and a control group with no treatment. Lasotronix uses a 635nm wavelength laser designed for safe and effective bio-stimulation and photo-disinfection, while CPP-ACP paste aims to reduce pain by managing dentin sensitivity. Participants aged 25 to 65 with at least one sensitive, vital tooth without decay or defective restoration will be involved. They will undergo treatment and follow-up to assess dentin hypersensitivity over three months. Researchers will monitor pain levels and treatment effects, ensuring safety and adherence to the study protocol throughout the trial period.

CONDITIONS

Brief Title

A Clinical Trial to Compare Lasotronix Alone or in Combination With CPP-ACP to Treat DH

Who Can Participate

Age: 25Years - 65Years

All Genders

Healthy Volunteers

Eligibility Criteria

You may qualify if you...

Patients of any gender aged 25 to 65 years
Must have at least one sensitive and vital tooth without decay or defective restoration

You will not qualify if you...

History of desensitizing therapy on the affected tooth in the last six months
Use of antibiotics, analgesics, or anti-inflammatory drugs
History of smoking
Pregnancy
Not willing to participate or attend follow-ups

Research Team

Sanam Dr Faheem, MSc

Chandar Dr Kumar

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here